ACTRN12615000586516已完成未知
An observational case-control study to detect predisposition to 5-fluorouracil/capecitabine-related toxicity using a thymine test in gastrointestinal cancer patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 37
研究概览
简要总结
The test appears to be able to distinguish patiients at risk of 5-FU related GI toxicity. A prospective study to confirm these findings is ongoing
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients diagnosed with histologically confirmed gastrointestinal cancers or metastatic breast cancer; about to start or have commenced therapy with single agent 5FU or capecitabine
排除标准
- •Pregnant or breast feeding; concurrent adbominopelvic radiation therapy
研究者
相似试验
已完成
2 期
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And LapatinibNeoplasms, Gastrointestinal TractNCT00526669GlaxoSmithKline68
撤回
2 期
A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerColorectal CancerNCT00388700Galectin Therapeutics Inc.
已完成
不适用
Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon CancerColon CancerNCT00994864Jules Bordet Institute235
已完成
不适用
Pepsin in Patients With Functional DyspepsiaAbdominal PainNauseaVomitingFlatulenceDyspepsiaFunctional Gastrointestinal DisordersNCT03076411Nordmark Arzneimittel GmbH & Co. KG97
Unknown
不适用
Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar ProteinosisPulmonary Alveolar ProteinosisNCT05300360TRPHARM15